2026 BioNJ Legal Compliance & Regulatory Forum Webinar
Side Effects May Include Longer Commercials: The Coming Fight Over DTC Advertising Thursday, October 29 | 11:00 a.m.-12:00 p.m. | Webinar FDA is considering rulemaking that could fundamentally reshape DTC advertising by eliminating the “major statement” and “adequate provision” paradigm for broadcast advertising of prescription drugs. Practically, this would require
